Zepbound (Tirzepatide), The FDA Approved Weight Loss Drug That Treats Sleep Apnea

The weight loss drug, Tirzepatide or Zepbound can treat obstructive sleep apnea with significant reduction in the apnea hypopnea index (AHI) which means reduced number of breathing disruptions during sleep per hour.
Tirzepatide is licensed for treating type 2 diabetes and obesity, and manufacturers, Lilly have conducted trials that showed Zepbound alone or Zepbound with CPAP (continuous positive airway pressure) helps for sleep apnea.

What is obstructive sleep apnea
Obstructive sleep apnea occurs when the throat muscles relax and block the airway. This leads to snoring and episodes of breathing disruptions through the night that can last for few seconds.
Daytime symptoms of sleep apnea include brain fog, fatigue, headaches, poor concentration, feeling sleepy during the day.

Risk factors and causes of sleep apnea include narrow airway, high blood pressure, diabetes type 2, obesity, smoking, male sex

People who suffer from sleep apnea are at risk of high blood pressure, heart disease, and strokes.

Sleep apnea is diagnosed using sleep studies and depending on severity of symptoms and underlying cause, treatment is with CPAP or surgery.

[mrjcbuc]

So, what in particular makes zepbound recommended for osa compared to the other weight loss drugs?